Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics

Gram-negative resistance remains a major challenge. Rates of in vitro resistance to commonly utilized antibiotics have skyrocketed over the last decade. Clinicians now encounter multidrug-resistant organisms routinely. Fortunately, newer agents, such as ceftazidime–avibactam, ceftolozone–tazobactam,...

Descripción completa

Detalles Bibliográficos
Autores principales: Waters, Jessica, Shorr, Andrew F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294883/
https://www.ncbi.nlm.nih.gov/pubmed/37370296
http://dx.doi.org/10.3390/antibiotics12060977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294883/
https://www.ncbi.nlm.nih.gov/pubmed/37370296
http://dx.doi.org/10.3390/antibiotics12060977

Ejemplares similares